FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / Press Releases / Read Press Release


Hercules Capital Provides $100MM Debt Facility to Tricida

March 06, 2018, 07:00 AM
Filed Under: Pharmaceuticals

Tricida, Inc., a South San Francisco, CA-based late-stage pharmaceutical company, entered into a $100 million venture debt facility with Hercules Capital, Inc.

Tricida drew down $25 million from the venture debt facility at closing. An additional $50 million will be available for drawdown subject to the achievement of future milestones. The remaining $25 million will be available for drawdown subject to approval by Hercules.

The company intends to use the funds to continue the development of TRC101 for the treatment of metabolic acidosis in chronic kidney disease patients.

The company currently has 26 employees.

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.